retatrutide oral Lilly orforglipron GLP-1 phase 3 weight loss trial Retatrutide pill form: why no
Description
These agents are effective for moderate to severe disease and maintaining remission
Participants entered the base cohort only once, when diabetes criteria were met (i.e., on their first inpatient visit, or the second outpatient visit with a diagnosis of T2D)
CONCLUSIONS CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported
Retrograde tracing For retrograde tracing experiments, Alexa 488-conjugated cholera toxin B subunit (CTB green ) was injected unilaterally at 0.05 L/min into the LH (0.3 L
